New Evidence Supports the Use of MDMA – the Drug in Ecstasy – in PTSD Treatment

A popular and divisive body of research around using hallucinogens, such as LSD and ketamine, for treating mental health conditions has emerged in the last decade. The most compelling evidence so far backs the efficacy of MDMA — colloquially called ecstasy — in treating post-traumatic stress disorder (PTSD). MDMA-assisted psychotherapy sessions were helping to alleviate PTSD, not simply suppress symptoms, according to a new analysis of clinical trials over the last six years points. When used in a regulated, controlled way, experts think it could prove a formidable treatment option for individuals who don’t respond to existing recovery channels.

The most recent meta-analysis, published in the Journal of Clinical Pharmacology, involved sending a questionnaire to participants who had their last MDMA session 12 months ago. The results were such: 86% of participants said they received substantial benefits; 84% reported improved feelings of well-being, 71% had fewer nightmares; 69% had less anxiety; 66% had improved sleep.

Amanda Smith - designer